Translational Development Acquisition shareholders approve charter extension amendment at special meeting

Translational Development Acquisition Corp.

Translational Development Acquisition Corp.

TDAC

0.00

  • Translational Development Acquisition Corp. held an extraordinary general meeting on June 17, 2026.
  • Shareholders adopted a charter amendment allowing up to 12 one-month extensions of the business-combination deadline from June 24, 2026 to June 24, 2027.
  • Following that approval, the company executed a trust agreement amendment enabling the same extensions, subject to notice and a deposit per extension.
  • Each one-month extension requires a deposit into the trust account of the lesser of $200,000 or $0.03 per outstanding public share.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Translational Development Acquisition Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-075471), on June 18, 2026, and is solely responsible for the information contained therein.